C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events.
about
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial diseaseLDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial diseaseIncreased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.Novel markers of peripheral arterial disease.Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-κB activation in mouse peritoneal macrophages.Aortic aneurysms: an immune disease with a strong genetic componentA biomarker panel for peripheral arterial disease.Biomarkers of peripheral arterial disease.Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitionersC-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularizationAn integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgeryThirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypassRisk assessment in the patient with established peripheral arterial disease.Ethnicity and peripheral artery disease.Pain frequency, severity and QT dispersion in adult patients with sickle cell anemia: correlation with inflammatory markers.White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial diseaseThe burden of peripheral artery disease and the role of antiplatelet therapy.Peripheral arterial disease in the Middle East: Underestimated predictor of worse outcome.High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease?C-reactive protein level in severe stenosis of cerebral arteries.Multiple biomarkers for mortality prediction in peripheral arterial disease.Inflammation and platelet activation in peripheral arterial occlusive disease.Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease.Anti-inflammatory mechanisms of the Tibetan herbal preparation Padma 28 in the vessel wall.C-reactive protein gene polymorphisms (rs1205) in Asian Indian patients with Takayasu arteritis: Associations and phenotype correlations.Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease.Relationship between high-sensitivity C-reactive protein and risk factors in patients with peripheral arterial disease--a cross-sectional study.Predictive value of neutrophil to lymphocyte ratio for the presence of coronary artery ectasia in patients with aortic aneurysms.Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?DETECTION OF CASPASE-3, NEURON SPECIFIC ENOLASE, AND HIGH-AENSITIVITY C-REACTIVE PROTEIN LEVELS IN BOTH CEREBROSPINAL FLUID AND SERUM OF PATIENTS AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE
P2860
Q26745592-D9F57B8A-2572-4D8C-B916-A8B1D45D5B1AQ30422549-49209A24-78A3-401B-91F1-EDD929E2FB8DQ30432040-ED80AAA3-1676-44F7-8004-6D5C73B2B999Q33860219-9822BA8E-63F3-4D74-B369-6B93EA3B99B3Q33886125-59B768A4-0E79-4680-B7B0-D847BF9CB9E7Q33984026-9FA088F2-CECA-4BC2-8507-077A785C191BQ34157980-EAA65A11-2C90-4927-A2E4-19FCF1FB0088Q34402629-D8A2E7F1-4416-4CC5-BCE3-68B7E1C97EF2Q35098249-86B7CBDC-385B-4833-9260-A05D72C310F8Q35170187-65F341AE-2DD1-457A-9361-6CC5BC74D212Q35753098-3D68FCC8-6454-4B12-9399-B1C946DF2FB9Q35765654-582CCCF8-E616-43BA-B8D8-731EAA159D75Q36146980-474A7DBE-B253-40EE-A436-B244368A22F2Q36369429-3024F34C-634D-4444-ACCD-55F4C13A4DBCQ36487375-E23B4FA3-E9B3-45E0-BA43-6AF71FBBFCECQ37019601-CABA6D2E-2E98-4488-8059-5C676B7B1AEFQ37307276-E8465DC7-8D32-4DC2-8E64-4D5E3F74C8ABQ37398404-3A67FD77-A710-4395-A09C-C4C5CE3B46B1Q37445745-D05C219D-8AB6-4475-BA4F-FC2D34133E05Q37566082-4E81D024-D679-4201-8725-D350D742CA82Q37659222-4A626D91-46FB-4245-8445-3D5D85845D78Q37980496-BD685C46-7DDB-4EB6-88DA-613366027895Q39792287-F933C7DC-EE12-4689-86EF-6F1AFF9FCC66Q40112794-DEB6EC26-BD25-4A01-ADBC-B5A94E6918EBQ42536670-D2A2A96F-D633-4E72-A781-5799C26B1BBAQ46664849-8C23688E-9C29-406F-AC23-27E7877B0747Q47214550-77EC1D6A-FAC1-401F-9ECE-1A3A982CC18BQ47291266-C42DE69A-A732-4E74-A2B3-07060610B567Q48651909-CEA77281-2E96-41A9-AC62-8225E140CC99Q48698039-FFA91FB5-BEF3-4A2E-829D-3FE9B79B3015Q49954021-439D353D-1068-4D0E-A576-046AC3708E2EQ50619725-55CBA5B9-B8B1-4375-A6C1-1D778B59DE09Q57925649-5F2344F7-AB45-42F6-B369-35D846AE9DD2
P2860
C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
C-reactive protein in peripher ...... future cardiovascular events.
@en
type
label
C-reactive protein in peripher ...... future cardiovascular events.
@en
prefLabel
C-reactive protein in peripher ...... future cardiovascular events.
@en
P2093
P1476
C-reactive protein in peripher ...... future cardiovascular events.
@en
P2093
Cathrien A Bruggeman
Eric L L Twiss
Frank R M Stassen
Luc H J M van den Akker
Marja P van Dieijen-Visser
Peter J E H M Kitslaar
Rick de Graaf
Rob J Th J Welten
Selma B Herngreen
Tryfon Vainas
P304
P356
10.1016/J.JVS.2005.03.060
P577
2005-08-01T00:00:00Z